BioTime, Inc. (BTX) Starts Presentation at LD Micro Conference

BioTime, Inc., a biotechnology company, is involved in the research and development of therapies based on stem cell technology, or regenerative medicine designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTime’s focus is on pluripotent stem cell technology based on human embryonic stem cells and induced pluripotent stem cells, which provide a means of manufacturing every cell type in the human body and show considerable promise for the development of new therapeutic products. For more information, visit the company’s website at www.biotimeinc.com.